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Medicine, Seoul 120-752, Korea
Adaptive brain function and synaptic plasticity rely on dy-
namic regulation of local proteome. One way for the neuron 
to introduce new proteins to the axon terminal is to transport 
those from the cell body, which had long been thought as the 
only source of axonal proteins. Another way, which is the 
topic of this review, is synthesizing proteins on site by local 
mRNA translation. Recent evidence indicates that the axon 
stores a reservoir of translationally silent mRNAs and regulates 
their expression solely by translational control. Different stimuli 
to axons, such as guidance cues, growth factors, and nerve in-
jury, promote translation of selective mRNAs, a process requi-
red for the axon’s ability to respond to these cues. One of the 
critical questions in the field of axonal protein synthesis is how 
mRNA-specific local translation is regulated by extracellular 
cues. Here, we review current experimental techniques that can 
be used to answer this question. Furthermore, we discuss how 
new technologies can help us understand what biological pro-
cesses are regulated by axonal protein synthesis in vivo. [BMB 
Reports 2015; 48(3): 139-146]
INTRODUCTION
A typical cell biology textbook published 20 years ago would 
state that all proteins in the axon of a vertebrate neuron come 
from the cell body. This ‘tenet’ of neuronal cell biology was 
based on thorough transmission electron microscopic ob-
servations of the sections from the adult rat brain, where the 
polyribosomes and rough endoplasmic reticulum were mainly 
found in neuronal cell bodies (1). In closer investigations, it 
was found that polyribosomes also localize to the base of den-
dritic spines (2). This finding immediately suggested a novel 
explanation to a long unanswered question in neuronal cell bi-
ology - how a new protein, synthesized in the cell body, is de-
livered to a specific postsynaptic site in highly complex den-
dritic arbors. The activated postsynapse can make the required 
protein on site by local mRNA translation (2). This idea led to 
a series of important discoveries that have firmly established 
local protein synthesis as one of key mechanisms underlying 
activity-dependent structural changes in the synapse (3). In 
contrast to the dendrite, however, polyribosomes were not 
readily detected on the other side of the synapse, the axon 
terminal. Moreover, most of the polyribosomes found in the 
axon localized to the axon initial segment, which is rather a 
‘postsynaptic’ site for inhibitory synapses than a presynaptic 
structure (4). This observation led to a speculation that local 
protein synthesis may occur prevalently in postsynaptic sites, 
and evidence for protein synthetic machinery in axons in cul-
ture (5, 6) and in vivo (7) did not draw much attention until the 
1990’s, perhaps due to this rather strong notion. It was not un-
til the early 2000’s when two independent studies convinc-
ingly showed that axonal protein synthesis is required for spe-
cific biological processes such as chemotropic responses of 
growth cones (8) and potentiation of neurotransmitter release 
(9). These discoveries led to a rebirth of the field of axonal pro-
tein synthesis. Many follow-up studies have showed that di-
verse vertebrate neuronal axons are capable of local protein 
synthesis both during development and in adulthood and have 
identified several axonally localized mRNAs, whose local 
translation is required for axon guidance, elongation, survival, 
and regeneration (references in (10)).
　The next goal in the field was to construct a comprehensive 
catalog of axonally localized mRNAs. Several genome-wide 
transcriptome analyses were performed aiming to gain insights 
into the roles that axonal protein synthesis may play, from the 
list of proteins that can be made from axonal transcriptome 
(11-15). However, unexpectedly large numbers of mRNAs 
were found in axons (sometimes thousands), which encode a 
variety of protein family members (even proteins that one 
would not normally expect there, such as transcription factors). 
Intriguingly, the contents of an axonal transcriptome is regu-
lated by aging (15) and extrinsic cues (16), and only a select 
few of axonally localized mRNAs are translating at any given 
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Fig. 1. Adaptive gene expression in the axon by local mRNA 
translation. Fig. 2. Methods to collect pure axons.
Technique Consistency Purity Yield Selectivity (1) Fluidic separation Explant culture? Accessibility
Campenot chamber Normal Good Good Good Good Yes Good
Modified Boyden chamber Good Normal Very good Low No Yes Very good
Microfluidic device Good Very good Moderate Very good Very good With modification Good
Laser-capture microdissection Very good Excellent Low Excellent No Yes Low
(1) Whether subcellular compartments within the axon can be selectively collected. Multi-chambered Campenot chambers and microfluidic device 
may be used to isolate proximal, middle and distal axons, separately Laser-capture microdissection allows selective isolation of minute structures 
such as the growth cone.
Table 1. Comparison of compartmentalized axon culture platforms
time (17). These results suggest that axons store mRNAs en-
coding proteins that are required in the near future and trans-
late them only when required (Fig. 1).
　At this time, conducting research on axonal protein syn-
thesis often means asking one or all of the following questions: 
i) whether a particular protein is locally synthesized in the ax-
on, ii) how the mRNA encoding that specific protein is chosen 
for translation from thousands of axonally localized mRNAs, 
and iii) what roles selective translation of that mRNA plays in 
the axon. Strategies to answer these questions differ depending 
on whether one has a particular protein of interest (candidate- 
based approach) or not (unbiased approach), but generally in-
volve a combination of techniques in compartmentalized cell 
culture, molecular biology, biochemistry, and imaging. These 
methods can also be applied to study dendritic protein syn-
thesis, but axons are more amenable for experiments as they 
are generally longer and therefore easier to isolate from their 
cell bodies. 
UNBIASED SCREENS FOR AXONALLY SYNTHESIZED 
PROTEINS
The ultimate evidence that a particular protein is locally syn-
thesized in the axon is that its abundance increases in mRNA 
translation-dependent manner in axons that are physically sep-
arated from their cell bodies. In unbiased screens, one selecti-
vely labels and/or purifies such proteins and identifies them by 
mass spectrometry (MS). Extracting proteins from axons with-
out any trace of their cell bodies is critical, because slight con-
tamination of somal proteins will lead to misidentification of 
axonally synthesized proteins. For this reason, all unbiased sc-
reens for axonally synthesized proteins published so far were 
conducted in cell culture systems, in which cell bodies can be 
experimentally eliminated from axons (which is often con-
firmed by absence of genomic DNA in axon lysate). For the 
same reason, proteins identified in unbiased screens must be 
validated by independent approaches, which are often imag-
ing-based (see “Confirmation of axonal protein synthesis”). We 
start this section by introducing most common cell culture 
platforms used to separate axons from their cell bodies (Fig. 2 
and Table 1).
Preparation of ‘axon-only’ culture
Campenot chamber: The Campenot chamber is the first device 
designed specifically for compartmentalized axon culture (18). 
It is a scaffold made of Teflon (a material known for non-stick 
coating of cooking pans), which is attached to a cell culture 
dish or cover glass via silicone grease (Fig. 2A). Currently, 
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there are many variations of the original three-chamber design, 
in which the dissociated neurons are plated in the central, or 
“proximal” compartment. Neuronal cell bodies and proximal 
neurites remain in the proximal chamber, and only the long 
neurites (which are likely to be axons) can pass through the sil-
icone grease-culture dish interface under the Teflon divider in-
to the “distal” compartments. With a complete seal, decent flu-
idic separation between compartments can be made, and axo-
nal growth into the distal compartments is facilitated by se-
lective addition of growth factors, such as nerve growth factor 
(NGF), to the “distal” compartments. The use of Campenot 
chambers involves relatively simple procedure (19) with com-
mercially available resources. If a stable and uniform seal is 
made between the Teflon barrier and culture dish, it is possi-
ble to culture a pure population of axons with virtually no 
trace of cell bodies. In order to make a stable seal, however, 
the width of the barrier should be relatively large (＞1 mm), 
which makes its use limited to neurons with very long axons. 
The making of a consistent seal requires training. 
Modified Boyden chamber: The Boyden chamber was origi-
nally designed to study leukocyte migration, and it is made up 
of a porous cell culture insert that separates the cell culture 
dish into two compartments (20) (Fig. 2B). The size of pores 
can be modified so that only the axons can pass through them 
and into the distal compartment (approximately 1 m), and the 
inserts with various pore sizes are commercially available. 
Neuronal cell bodies are plated on the upper surface of the in-
sert, and axonal growth into the lower compartment is facili-
tated by selectively coating the lower surface of the insert with 
extracellular matrix (ECM) molecules (such as laminin) (21). 
The main advantage of this method is that the culture proce-
dure is straightforward and that tissue explants (such as pieces 
of the brain and spinal cord) can be used without any 
modification. After axons grow into the lower “distal” compart-
ment, all the cells in the upper “proximal” compartment can 
be removed by suction and scraping. With meticulous elimi-
nation, one can obtain pure axons with no detectable nuclear 
DNAs. Two main disadvantages of this method are that there 
is no fluidic separation between chambers (therefore cell bod-
ies should be physically removed before any chemical stim-
ulation, if axon-specific stimulation is required), and that it is 
difficult to get clear images of axons grown on a porous insert 
(plasma membrane can be stained with a fluorescent dye to 
improve image quality).
Microfluidic device: Microfluidic device was developed along 
the original idea of Campenot, but new material of transparent 
and biologically inert polymer (polydimethylsiloxane, or 
PDMS) was utilized (22). The PDMS device often contains two 
symmetrical chambers separated by narrow “microgrooves”, 
through which only axons can grow. Gently pressing a dry 
PDMS mold on a dry coverslip or culture dish makes a water-
tight seal (Fig. 2C). Plating dissociated neurons in one chamber 
(“proximal” compartment) over a sufficient period of time al-
lows axons to grow through the microgrooves into the other 
chamber (“distal” compartment). The main advantage of this 
technique is that almost perfect fluidic isolation between the 
two compartments can be achieved, simply by adjusting the 
volume of culture medium in each compartment. For example, 
when more culture medium is added to the proximal compart-
ment, any chemical treated into the distal compartment will re-
main there because of the negative hydrostatic pressure in the 
microgrooves (Fig. 2C). PDMS molds with different sizes of mi-
crogrooves and chambers are commercially available or can 
be micro-fabricated. The microgrooves can be made sig-
nificantly shorter than the barrier of the Campenot chamber (as 
short as 150 m), and therefore, this method can be used for 
short axons and even for long dendrites. The transparency of 
PDMS makes it particularly suitable for live imaging. One dis-
advantage is that it is more expensive than other methods 
(unless you have access and expertise in micro-fabrication). 
Also, it takes some experience to make a good seal between a 
PDMS mold and ECM molecule-coated coverslip. Neurons 
that are plated not close enough to the microgrooves will not 
grow their axons into the distal compartment and therefore 
will be wasted. Plating the dissociated neurons close to the mi-
crogrooves also requires experience. Most commercially avail-
able PDMS molds may not be suitable for tissue explant cul-
ture, as cells have to be plated in a closed chamber that is cov-
ered by ∼100 m-high roof. 
Laser-capture microdissection: In laser-capture microdissec-
tion (LCM), one can dissect the selected regions from a tissue 
section or cell culture while directly observing the sample un-
der the microscope (23) (Fig. 2D). To collect axons, individual 
axons are microdissected from neuron culture grown on an 
LCM-compatible slide. Neuron culture may be pre-stained 
with a fluorescent dye to aid visualization. This method pro-
vides the most precise way to collect axonal materials and en-
ables subcellular compartment-specific microdissection of the 
axon (for example, axon shafts versus axon terminals) (15), 
which is not possible in any other compartmentalized cell cul-
ture systems. However, microdissection of individual axons 
means that one has to collect thousands of axons to obtain 
enough proteins or mRNAs for analysis. And it is sometimes 
necessary to fix the sample, because axons in culture are high-
ly dynamic. LCM microscopes are generally expensive.
Selective labeling and identification of axonally synthesized 
proteins
In order to detect proteins that are locally synthesized in re-
sponse to extrinsic cues, replicates of somaless axon culture 
are prepared by one of the methods described in the previous 
section, leaving one culture untreated and treating others with 
specific cues. Because severed axons can survive only for sev-
eral hours in culture, any increase in protein abundance dur-
ing cue stimulation may only be small and difficult to detect. It 
is particularly so, when an extrinsic cue promotes the synthesis 
of a protein that pre-existed in high abundance. Therefore, it is 
advantageous to analyze newly synthesized proteins, or the de 
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Fig. 3. Methods to identify axonally synthesized proteins.
novo proteome, rather than the steady-state proteome. Two 
standard biochemical approaches are available for selective la-
beling of de novo proteome: metabolic labeling of protein syn-
thesis and puromycin tagging of nascent polypeptides (Fig. 3 
and Table 2). 
Metabolic labeling of protein synthesis: Metabolic labeling uti-
lizes tagged amino acids, which live axons can use as building 
blocks for protein synthesis. Proteins synthesized after the ad-
dition of tagged amino acids are thus selectively labeled, 
which can be visualized, purified, and/or directly identified by 
MS (Fig. 3 and Table 2). Bioorthogonal noncanonical amino 
acid tagging (BONCAT) (24) and stable isotope labeling by 
amino acids in cell culture (SILAC) (25) are well-established 
techniques. 
　Tagged amino acids can be applied to severed axons (which 
can be cultured for several hours) or to intact axons cultured in 
a microfluidic device (or a well-prepared Campenot chamber). 
The latter method has advantages of avoiding the need to cut 
axons and being able to label axons for longer periods of time 
(over days). But, there is a risk that tagged amino acids may 
leak into the proximal compartment, which may label somal 
proteins that may be transported to axons. This will lead to 
false identification of axonally synthesized proteins and ruin 
the entire experiment. The former method can be done in di-
verse compartmentalized chambers, such as the Boyden cham-
ber that gives a higher yield of axons, but severing axons may 
initiate unnecessary cellular responses. 
　BONCAT utilizes amino acid analogs, such as the Met ana-
log aziodohomoalanine (AHA), which contains an azide 
group. Axons are treated with AHA, which is used for protein 
synthesis, resulting in labeling of de novo axonal proteome 
with the bioorthogonal azide group. These proteins are then 
covalently linked to an alkyne containing tag, such as fluo-
rescent dyes or biotin, by Click chemistry (24). De novo axo-
nal proteomes tagged to fluorescent dyes can be quantitatively 
analyzed by 2-dimensional differential gel electrophoresis 
(2D-DIGE) (17), and those tagged to biotin can be directly iso-
lated by streptavidin affinity purification.
　Once inside the axon, AHA is first charged to tRNAmet by the 
enzyme Met-tRNA synthetase before being used for protein 
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synthesis. AHA charged to tRNAmet then incorporates itself into 
Met residues of nascent peptides during mRNA translation. 
The formation of AHA- tRNAmet takes minutes, which means 
that there is always a lag between AHA treatment and actual 
proteome labeling. Axons should be cultured in Met- free cul-
ture medium to increase labeling efficiency, because AHA 
competes with Met for tRNAmet and Met-tRNA synthetase.
　SILAC utilizes amino acids containing stable isotopes (such 
as 3H, 13C or 15N), which can be used for protein synthesis. 
Similarly to BONCAT, SILAC requires time for the probe ami-
no acids to be charged to appropriate tRNAs and specific ami-
no acid-free medium (for example, Lys-free medium to use 
13C-Lys) to increase labeling efficiency. Incorporation of the 
“heavy” amino acids (e.g. 13C-Lys) causes a predictable mass 
shift from the normal “light” amino acid (e.g. 12C-Lys). Heavy 
amino acid labeling causes no other chemical or functional 
changes to the labeled proteins, and therefore SILAC is 
noninvasive. By contrast, BONCAT may affect function of the 
protein it labels, because a noncanonical amino acid replaces 
an endogenous amino acid (e.g. AHA replaces Met). Another 
advantage of SILAC is that the labeled proteome can be di-
rectly identified by MS without any purification. Pre-existing 
proteome, which is "labeled" by the light isotope, can be dis-
tinguished by MS, and normalizing de novo proteome to 
steady state proteome enables quantitative analysis. In con-
trast, the BONCAT method normally requires purification of 
labeled proteome before their identification, which reduces 
the yield of protein recovery and produces biased enrichments 
of proteins. The recently developed technique for direct identi-
fication of biotinylated proteins by MS (26) may increase effi-
ciency and accuracy of BONCAT-based analyses.
Puromycin labeling of nascent polypeptides: Puromycin tag-
ging approach utilizes puromycin derivatives, which cause 
premature translation termination by incorporating themselves 
into the C terminus of nascent polypeptides. Therefore, this 
method differs from metabolic labeling approaches in the sen-
se that it takes a snapshot of axonal protein synthesis at the 
time of puromycin treatment. Puromycin treated to axons ly-
sate, as well as live axons, causes translation termination, and 
thus this approach does not require live axons. Instead, axon 
lysate can be obtained from intact neuron culture in the pres-
ence of emetine (which is an inhibitor of translation elonga-
tion, but unlike cycloheximide does not inhibit puromycin in-
corporation) (27). Biotinylated puromycin is added to axon ly-
sate, labeling each translation-stalled, nascent polypeptide 
with a single puromycin tag at its carboxy terminus. These 
peptides are affinity-purified using streptavidin and identified 
by MS, but this may be combined with a recent technique to 
directly identify biotinylated proteins (26). 
Selective isolation of axonally translating mRNAs
Most proteomic approaches utilize MS for protein identi-
fication. MS-based identification is less sensitive than DNA- 
based detection technologies, such as deep sequencing, main-
ly because proteins cannot be amplified or fully sequenced. 
Therefore, although analyzing proteins is the most accurate 
way to study axonal protein synthesis, the use of nucleic 
acid-based technologies has its own merits. Nucleic acid- 
based approaches utilize the same principle of puromycin ta-
gging. Information on de novo proteome is obtained from 
translation-stalled, ribosome-mRNA complexes. Instead of ana-
lyzing nascent polypeptides, however, this approach utilizes 
highly sensitive DNA-based technologies to get the sequence 
information of translating mRNAs. Ribosome-mRNA complexes 
can be purified either by the traditional polysome fractionation 
technique or ribosome immunoprecipitation. The particular 
strength of the latter approach, which is known as translating 
ribosome affinity purification (TRAP), is that a tagged ribosomal 
protein can be genetically encoded, enabling cell type-specific 
ribosome tagging (28). 
Axon-TRAP: Like the puromycin tagging approach, TRAP takes 
a snapshot of axonal protein synthesis from axon lysate iso-
lated from intact neurons. One advantage of this technique 
over biochemical approaches is that mRNAs can be identified 
by the RNA sequencing technology. This is not only more sen-
sitive in identifying axonally synthesized proteins than MS, but 
it also has potential to identify regulatory cis-element in un-
translated regions (UTRs). The second advantage, which may 
have a stronger impact, is that it can be used to study axonal 
translation in vivo. For example, the tagged ribosome can be 
selectively expressed in particular neurons, whose cell bodies 
are localized to one part of the brain (in vivo “proximal” com-
partment) and axons are localized to another part of the brain 
(in vivo “distal” compartment in culture). Although in vivo 
“distal” compartment may contain other cells in addition to 
the axons of interest, these cells do not express the tagged 
ribosome. Therefore, axonal ribosomes can be selectively re-
trieved from the lysate of the in vivo “distal” compartment, by 
affinity-purification. In this way, the mRNAs translating in ax-
ons of particular neurons can be isolated from an intact brain. 
The plausibility of this technique, axon-TRAP, has been con-
firmed recently, although it was used to measure translation of 
a few candidate mRNAs (17). It will be possible to perform 
RNA sequencing analysis of axon-TRAPed mRNAs in the fu-
ture, which will reveal genome-wide information on the entire 
set of axonally translating mRNAs (translatome). One draw-
back of this technique is that ribosome immunoprecipitation 
does not distinguish ribosome-bound, translationally inactive 
mRNAs (which are often in RNA granules) from actively trans-
lating mRNAs. Combining axon-TRAP with ribosome run-off 
(29) or ribosome profiling (30) will enable us to perform a more 
accurate survey of axonal protein synthesis in vivo.
CONFIRMATION OF AXONAL PROTEIN SYNTHESIS
Regardless of whether one has found candidate mRNAs from 
unbiased screens or reasoning, their axonal synthesis must be 
experimentally validated. Because it is difficult to obtain 
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enough axonal proteins for standard biochemical assays such 
as Western blotting, researchers often take a reasonable alter-
native, imaging based approaches, to measure local synthesis 
of a specific protein.
Quantitative immunofluorescence (QIF)
In QIF, the relative amount of a protein is measured by quanti-
tative immunolabeling of fixed neurons, followed by quantita-
tive fluorescent microscopy. Net immunofluorescence in the 
axon (i.e. fluorescent intensity in axon subtracted by back-
ground fluorescent intensity) represents the relative amount of 
the protein, which the antibody recognizes. To detect axonal 
protein synthesis, somaless axons are treated with an extrinsic 
cue or vehicle, and the abundance of a specific protein in ax-
ons is compared between groups. An increase in protein abun-
dance, which can be blocked by translation inhibitors, in-
dicates the axonal synthesis of that protein (8).
Live imaging of translational reporter fluorescence
It is well accepted that most cis-elements regulating translation 
of an mRNA reside in UTRs, particularly in the 3’-UTR. By ex-
pressing a chimeric mRNA consisting of the protein-coding se-
quence of a fluorescent protein and the UTRs of the gene of in-
terest, translation of a particular mRNA can be visualized in re-
al time. Membrane-targeted, destabilized fluorescent proteins 
are common reporter proteins, because they are not diffusible 
(therefore any fluorescence results from the local source) and 
are short-lived (therefore any fluorescence results from de no-
vo protein synthesis) (31). Use of photoconvertible fluorescent 
de novo (such as Kaede and Dendra) (32) or fluorescent recov-
ery after photobleaching (FRAP) (31) are some of the alter-
natives to measure translation by imaging.
FUTURE DIRECTIONS
Although axons contain hundreds or thousands of different 
mRNAs, inhibiting cue-induced translation of one or a few 
mRNAs almost completely blocks the axon’s ability to respond 
to that cue (references in (33)), suggesting that cue-induced 
translation of selective mRNAs mediates specific biological 
processes. In this sense, an important question is how the dif-
ferent extrinsic cues activate translation of specific mRNAs. 
The first step in answering this question will be systematically 
analyzing extrinsic cue/target mRNA relationships. Axon-TRAP 
from axons treated with different cues would provide valuable 
information, which will lead to discoveries of new cis- and 
trans-acting elements that regulate message-specific translation 
in the axon.
　Most of the unbiased screens for axonally synthesized pro-
teins have been performed in cultured axons, mainly because 
it was impossible to selectively label or purify proteins from 
axons in vivo, which are normally intertwined with other cells. 
In this sense, the second important question is which proteins 
are synthesized in axons in vivo. Currently, axon-TRAP is the 
only technology that allows us to identify axonally synthesized 
proteins in vivo. Although translatome gives accurate in-
formation on de novo proteome, it does not tell us what hap-
pens after new proteins are made. For example, it has been 
suggested that axonally synthesized -actin proteins differ from 
their pre-existing counterparts only by post-translational mod-
ification (34, 35), and this difference is key to newly made 
-actin’s ability to steer growing axons. Therefore, it will be 
important to develop new technologies that will enable direct 
and selective labeling of axonal proteome in vivo. A promising 
progress in this direction was recently made in Drosophila 
(36), and it will be exciting to see this technique applied to 
vertebrates.
　Answering the first two questions will increase the number of 
mRNAs whose axonal translation may play key roles in vivo. 
For the clear understanding of their function, technologies need 
to be developed, which can selectively interfere with mRNA 
translation in axons, while leaving translation  in the cell body 
intact. One promising strategy to decrease global translation ac-
tivity selectively in the axon is chemically-inducible, genet-
ically-encoded translational inhibitors (37, 38). Analogous to 
axon-TRAP, dormant inhibitor proteins could be expressed in 
specific neurons, whose cell bodies are localized to one part of 
the brain (in vivo “proximal” compartment). These inhibitor 
proteins could then be selectively activated in the axons of 
these neurons, by treating chemicals that induce inhibitor activ-
ity specifically to the other part of the brain, where their axon 
terminals are localized (in vivo “distal” compartment). To in-
hibit axonal translation of specific mRNAs, photoactivatable, 
caged antisense oligonucleotide (39) could be used, which can 
be delivered to specific neurons and uncaged selectively in the 
axon. An alternative approach is gene targeting of mRNA local-
ization elements. For example, one can knock out the ax-
on-specific splice variant, which contains a specific 3’-UTR, 
while leaving the entire protein coding region intact (40). This 
approach, however, requires the detailed knowledge on local-
ization cis-elements of the target mRNA.
　Recent development in DNA and protein detection tech-
nologies and new cell culture platform has made significant 
contribution to the field of axonal protein synthesis. Rapidly 
adopting and improving new technologies in diverse dis-
ciplines will be required to answer these remaining questions 
and pinpoint the biological significance of axonal protein syn-
thesis in vivo. 
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